CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 14,265 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 116 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 217 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 471 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 723 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,881 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 659 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 49,000 shares at $1.68 ($82,124)
- 4 Open-market buy Chief Financial Officer bought 8,832 shares at $1.70 ($14,999)
- 4 Open-market buy Chief Operating Officer bought 10,000 shares at $1.72 ($17,218)
- 4 Shares withheld for taxes President and CEO gave up 19,904 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)
Page 3 of 11 · 206 filings